Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...

Equities researchers at StockNews.com started coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) in ...

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) shares passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.54 ...

PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

There are hundreds of marijuana strains available throughout the legal marijuana industry, but a handful stand out among the ...

They were from the College of Agricultural and Environmental Sciences (CAES), College of Engineering, Design, Art and ...

Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has ...

Pheno Therapeutics Ltd. has received clinical trial authorization (CTA) from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its lead candidate, PTD-802. The program will ...

UK MHRA grants CTA for first-in-human trial of a selective GPR17 antagonist Small molecule therapeutic designed for treatment of neurological diseases such as multiple sclerosis Pheno Therapeutics ...